<--- Back to Details
| First Page | Document Content | |
|---|---|---|
 Date: 2016-07-11 16:59:22Medicine Biotechnology PEGylation Pharmacokinetics Pegloticase Savient pharmaceuticals Biology Health Urate oxidase Gout Uric acid Pharmaceutical industry in China |
Add to Reading List |
Microsoft Word - Savient Phase 3 Dosing press releasedoc | Microsoft Word - FDA Grants Priority Review to Pegloticase BLA FilingdocDocID: 1sopU - View Document |
| Conjugates prepared with aggregate-free proteins - European Patent Office - EPB1 Conjugates prepared with aggregate-free proteins - European Patent Office - EPB1DocID: 1rrGr - View Document |
| Peg-urate oxidase conjugates and use thereof - European Patent Office - EPB1 Peg-urate oxidase conjugates and use thereof - European Patent Office - EPB1DocID: 1rrm1 - View Document |
| Microsoft Word - Savient Press Release ACRdocDocID: 1rrcY - View Document |
| Microsoft Word - Savient Phase 3 Dosing press releasedocDocID: 1ri7E - View Document |